The GLP is committed to full transparency. Download and review our 2019 Annual Report

nn kda worlds most expensive drug x

Viewpoint: Spinal muscular atrophy treatment Zolgensma a gene therapy trailblazer, despite controversy

In August, the US Food and Drug Administration (FDA) gave drug manufacturer AveXis, Inc, a subsidiary of Novartis AG, a ...